SYRE   $33.7  0.30% Market Closed After Close 33.7 0.0

Spyre Therapeutics Inc
Total Cash 426.00M
totalCashPerShare 8.387
EBITDA -172.55M
Total Debt 235.00K
quickRatio 19.257
currentRatio 19.697
Total Revenue 0.00
debtToEquity 0.063
Revenue/Share 0.0
ROA -0.31805
ROE -1.02092
grossProfits
freeCashflow -260.72M
operatingCashflow -156.42M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.38B
forwardPE -8.77892
floatShares 35.34M
sharesOutstanding 50.92M
sharesShort 8.64M
sharesShortPriorMonth 8.46M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.04%
heldPercentInstitutions 1.00%
Short Ratio help_outline 13.59%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 4.304
Price To Book help_outline 7.93
earningsQuarterlyGrowth
netIncomeToCommon -185.98M
trailingEps 10.89%
forwardEps -3.89%
enterpriseToEbitda -7.98
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.82 3Q 2024
institutionsCount 161
lastUpdated Oct. 22, 2024, 11:30 p.m.